Chiara Corti

3.0k total citations · 2 hit papers
70 papers, 1.9k citations indexed

About

Chiara Corti is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chiara Corti has authored 70 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Oncology, 22 papers in Cancer Research and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chiara Corti's work include HER2/EGFR in Cancer Research (21 papers), CAR-T cell therapy research (14 papers) and Breast Cancer Treatment Studies (13 papers). Chiara Corti is often cited by papers focused on HER2/EGFR in Cancer Research (21 papers), CAR-T cell therapy research (14 papers) and Breast Cancer Treatment Studies (13 papers). Chiara Corti collaborates with scholars based in Italy, United States and France. Chiara Corti's co-authors include Giuseppe Curigliano, Paolo Tarantino, Sara M. Tolaney, Federica Giugliano, Carmen Criscitiello, Nicola Fusco, Javier Cortés, Elham Sajjadi, Eleonora Nicolò and Liliana Ascione and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and The Lancet Oncology.

In The Last Decade

Chiara Corti

65 papers receiving 1.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies

2021 275 citations Paolo Tarantino, Roberto Carmagnani Pestana et al. CA A Cancer Journal for Clinicians profile →
Combining antibody-drug conjugates with immunotherapy in solid tumors: current landscape and future perspectives

2022 147 citations Eleonora Nicolò, Federica Giugliano et al. Cancer Treatment Reviews profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Chiara Corti	1.3k	466	458	442	334	70	1.9k
Cinzia Solinas	1.7k 1.3×	421 0.9×	217 0.5×	445 1.0×	311 0.9×	80	2.4k
Stefania Morganti	1.1k 0.8×	349 0.7×	399 0.9×	403 0.9×	426 1.3×	56	1.5k
Mark Harries	1.1k 0.8×	579 1.2×	337 0.7×	221 0.5×	317 0.9×	62	1.9k
Paolo Tarantino	2.3k 1.8×	632 1.4×	1000 2.2×	826 1.9×	777 2.3×	128	3.2k
Philippe Aftimos	1.9k 1.5×	934 2.0×	690 1.5×	809 1.8×	785 2.4×	144	3.1k
Deborah B. Doroshow	1.4k 1.1×	745 1.6×	160 0.3×	611 1.4×	322 1.0×	62	2.2k
Alex Friedlaender	1.5k 1.1×	711 1.5×	140 0.3×	1.1k 2.5×	437 1.3×	86	2.3k
Bo Chen	758 0.6×	875 1.9×	155 0.3×	433 1.0×	440 1.3×	114	1.9k
Ron Yu	949 0.7×	724 1.6×	391 0.9×	344 0.8×	264 0.8×	32	1.7k
Luc Cabel	1.2k 0.9×	487 1.0×	177 0.4×	599 1.4×	924 2.8×	81	1.9k

Countries citing papers authored by Chiara Corti

Since Specialization

Citations

This map shows the geographic impact of Chiara Corti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Corti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Corti more than expected).

Fields of papers citing papers by Chiara Corti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Corti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Corti. The network helps show where Chiara Corti may publish in the future.

Co-authorship network of co-authors of Chiara Corti

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Corti. A scholar is included among the top collaborators of Chiara Corti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Corti. Chiara Corti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Batalini, Felipe, Leo Anthony Celi, Edward Christopher Dee, et al.. (2025). Global disparities in artificial intelligence-based mammogram interpretation for breast cancer: A scientometric analysis of representation, trends, and equity. European Journal of Cancer. 220. 115394–115394.

Corti, Chiara, et al.. (2024). Systemic Therapy in Breast Cancer. American Society of Clinical Oncology Educational Book. 44(3). e432442–e432442. 6 indexed citations

Schlam, Ilana, Chiara Corti, Sarah Sammons, Elizabeth A. Mittendorf, & Sara M. Tolaney. (2024). Checkpoint inhibition for early-stage hormone receptor-positive breast cancer. Expert Opinion on Biological Therapy. 24(6). 511–520. 3 indexed citations

Jain, Bhav, Chiara Corti, Neha Vapiwala, et al.. (2023). Second Malignancy Probabilities in Patients With Breast Cancer Treated With Conventional Versus Hypofractionated External Beam Radiation Therapy in the Adjuvant Setting. Clinical Oncology. 36(3). 183–192.

Antonarelli, Gabriele, Chiara Corti, Paolo Tarantino, et al.. (2023). Management of patients with HER2-positive metastatic breast cancer after trastuzumab deruxtecan failure. ESMO Open. 8(4). 101608–101608. 21 indexed citations

Spitaleri, Gianluca, Pamela Trillo Aliaga, Ilaria Attili, et al.. (2023). MET in Non-Small-Cell Lung Cancer (NSCLC): Cross ‘a Long and Winding Road’ Looking for a Target. Cancers. 15(19). 4779–4779. 12 indexed citations

Corti, Chiara, Edward Christopher Dee, Ilana Schlam, et al.. (2023). Advancing equitable and personalized cancer care: Novel applications and priorities of artificial intelligence for fairness and inclusivity in the patient care workflow. European Journal of Cancer. 198. 113504–113504. 3 indexed citations

Valenza, Carmine, et al.. (2023). Evolving treatment landscape of immunotherapy in breast cancer: current issues and future perspectives. Therapeutic Advances in Medical Oncology. 15. 4287558161–4287558161. 11 indexed citations

Corti, Chiara, Carmine De Angelis, Giampaolo Bianchini, et al.. (2023). Novel endocrine therapies: What is next in estrogen receptor positive, HER2 negative breast cancer?. Cancer Treatment Reviews. 117. 102569–102569. 36 indexed citations

10.

Criscitiello, Carmen, Chiara Corti, Michelino De Laurentiis, et al.. (2023). Tucatinib's journey from clinical development to clinical practice: New horizons for HER2-positive metastatic disease and promising prospects for brain metastatic spread. Cancer Treatment Reviews. 120. 102618–102618. 6 indexed citations

11.

Morganti, Stefania, Antonio Marra, Sara Gandini, et al.. (2023). Clinicopathological features and survival outcomes of luminal-like breast tumors with estrogen receptor loss at metastatic recurrence: A case-control study. European Journal of Cancer. 195. 113397–113397. 2 indexed citations

12.

Giugliano, Federica, Paolo Andrea Zucali, Giulia Galli, et al.. (2022). SARS-CoV-2 vaccine in patients with thymic epithelial tumours with and without active or pre-existing autoimmune disorders: Brief report of a TYME network safety analysis. European Journal of Cancer. 166. 202–207. 3 indexed citations

13.

Corti, Chiara, et al.. (2022). CAR-T cell therapy for triple-negative breast cancer and other solid tumors: preclinical and clinical progress. Expert Opinion on Investigational Drugs. 31(6). 593–605. 60 indexed citations

14.

Nicolò, Eleonora, Federica Giugliano, Liliana Ascione, et al.. (2022). Combining antibody-drug conjugates with immunotherapy in solid tumors: current landscape and future perspectives. Cancer Treatment Reviews. 106. 102395–102395. 147 indexed citations breakdown →

15.

Antonarelli, Gabriele, Federica Giugliano, Chiara Corti, et al.. (2021). Research and Clinical Landscape of Bispecific Antibodies for the Treatment of Solid Malignancies. Pharmaceuticals. 14(9). 884–884. 28 indexed citations

16.

Giugliano, Federica, Edoardo Crimini, Paolo Tarantino, et al.. (2021). First line treatment of BRAF mutated advanced melanoma: Does one size fit all?. Cancer Treatment Reviews. 99. 102253–102253. 24 indexed citations

17.

Aliaga, Pamela Trillo, Dario Trapani, José Luís Sandoval, et al.. (2021). Safety of COVID-19 mRNA Vaccines in Patients with Cancer Enrolled in Early-Phase Clinical Trials. Cancers. 13(22). 5829–5829. 10 indexed citations

18.

Tarantino, Paolo, Roberto Carmagnani Pestana, Chiara Corti, et al.. (2021). Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies. CA A Cancer Journal for Clinicians. 72(2). 165–182. 275 indexed citations breakdown →

19.

Lopez, Gianluca, Marianna Noale, Chiara Corti, et al.. (2020). PTEN Expression as a Complementary Biomarker for Mismatch Repair Testing in Breast Cancer. International Journal of Molecular Sciences. 21(4). 1461–1461. 25 indexed citations

20.

Carraro, Luciana, Cristina Zogmaister, Luciano Arcuri, Massimiliano Pastore, & Chiara Corti. (2013). On the factorial structure of self-esteem as measured by the Italian translation of the Self-Liking/Self-Competence Scale - Revised (SLCS-R). BOA (University of Milano-Bicocca). 8(3). 371–388. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact